Neuroscience
College of Humanities and Social & Behavioral Sciences
Dr. Gary Dunbar, Director
Health Professions Building 2182; 989-774-3282
Jamie Alan, Ph.D., University of North Carolina. Regulation of signal transduction pathways as they relate to development of cancer in c. elegans and in cultured human cells.
Richard W. Backs, Ph.D., University of Southern California. Human factors, psychophysiology, aging, attention, and emotion
Gary Dunbar, Ph.D., Clark University. Stem cell, dietary supplements, and pharmacological therapies for neurodegenerative diseases, including Huntington’s, Alzheimer’s, and Parkinson’s diseases
Kenneth Jenrow, Ph.D., Oakland University. Electrophysiology, mitigating neuroinflammation and its deleterious effects on synaptic plasticity and cognitive function.
Jamie Johansen, Ph.D., Michigan State University. Developing reliable mouse models of neurodegenerative diseases, such as Parkinson’s and Kennedy’s diseases, for testing potential therapies
Yannick Marchalant, Ph.D., université de Caen, France. Influence of brain aging and neuroinflammatory processes on the development of neurodegenerative diseases.
Kevin Park, Ph.D., University of Illinois at Urbana-Champaign. Molecular genetics and neurobiology of neurodegenerative diseases, preclinical therapeutic development.
Mark Reilly, Ph.D., West Virginia University. Experimental analysis of behavior, operant/respondent conditioning, animal learning, quantitative models, behavioral pharmacology, and substance abuse
Julien Rossignol, Ph.D., Nantes University, France. Molecular biology, cellular biology, and immunology. Optimizing adult stem cell transplantation technology in the context of neurodegenerative diseases.
Michael Sandstrom, Ph.D., Ohio State University. Assessing brain plasticity, compensatory neuronal activity, or neurochemical control during active behavior at various stages of deteriorative brain diseases such as Parkinson’s and Huntington’s using animal models
Reid Skeel, Ph.D., University of Florida. Functional applications of neuropsychological assessments.
Michelle Steinhilb, Ph.D., genetic models of human neurodegenerative disease, cellular and molecular neurobiology
Ksenia Ustinova, Ph.D, Russian State University of Sport. Motor control and learning, rehabilitation of patients with neurological diseases including stroke, spinocerebellar ataxia, Parkinson’s disease
Course Designator:
NSC - Neuroscience
The Programs:
Master of Science (M.S.) in Neuroscience
Doctor of Philosophy (Ph.D.) in Neuroscience